Dena Mary, Svensson Ann-Marie, Olofsson Katarina Eeg, Young Laura, Carlson Anders, Miller Kellee, Grimsmann Julia, Welp Reinhard, Mader Julia K, Maahs David M, Holl Reinhard W, Lind Marcus
Department of Medicine, NU Hospital Group, Uddevalla, Trollhättan, Sweden.
Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
Diabetes Ther. 2021 Dec;12(12):3093-3105. doi: 10.1007/s13300-021-01169-w. Epub 2021 Oct 25.
Renal complications are both a marker of previous suboptimal glycaemic control and a major risk factor for cardiovascular disease in persons with type 1 diabetes (T1D). The aim of the study was to evaluate the prevalence of renal complications in persons with T1D in four geographical regions.
Nationwide registry data from Austria/Germany, Sweden and the US were used to estimate the prevalence of renal complications from January 2016 until September 2018. Chronic kidney disease (CKD) and albuminuria in the study population and each registry were analysed by diabetes duration. Risk factors for renal complications were described by registry.
In the total cohort of 78.926 adults with T1D, mean age was 44.4 ± 18.43 years and mean diabetes duration was 21.6 ± 22 years. Mean estimated glomerular filtration rate (eGFR) was 94.0 ± 31.45 ml/min, 13.0% had microalbuminuria and 3.9% had macroalbuminuria. Mean age, diabetes duration, use of insulin pumps and continuous glucose monitoring, as well as presence of albuminuria, varied between registries. Albuminuria was present in approximately 10% of persons with diabetes duration < 20 years and impaired renal function (eGFR < 60 ml/min) was present in 17%. In persons with diabetes duration > 40 years, approximately one-third had albuminuria and 25% had impaired renal function.
This analysis used three nationwide registries of persons with T1D. Despite recent use of more effective diabetes therapies, a substantial proportion of persons with T1D have renal complications at < 20 years after diagnosis. Efficient glucose-lowering and renal-protective strategies are needed in persons with T1D.
肾脏并发症既是既往血糖控制不佳的标志,也是1型糖尿病(T1D)患者心血管疾病的主要危险因素。本研究的目的是评估四个地理区域T1D患者肾脏并发症的患病率。
使用来自奥地利/德国、瑞典和美国的全国登记数据,估计2016年1月至2018年9月期间肾脏并发症的患病率。按糖尿病病程分析研究人群及各登记处的慢性肾脏病(CKD)和蛋白尿情况。通过登记处描述肾脏并发症的危险因素。
在总共78926名成年T1D患者中,平均年龄为44.4±18.43岁,平均糖尿病病程为21.6±22年。平均估计肾小球滤过率(eGFR)为94.0±31.45ml/分钟,13.0%有微量白蛋白尿,3.9%有大量白蛋白尿。各登记处之间的平均年龄、糖尿病病程、胰岛素泵和持续血糖监测的使用情况以及白蛋白尿的存在情况各不相同。糖尿病病程<20年的患者中约10%存在白蛋白尿,17%存在肾功能受损(eGFR<60ml/分钟)。糖尿病病程>40年的患者中,约三分之一有白蛋白尿,25%有肾功能受损。
本分析使用了三个全国性的T1D患者登记处。尽管最近使用了更有效的糖尿病治疗方法,但相当一部分T1D患者在诊断后<20年就出现了肾脏并发症。T1D患者需要有效的降糖和肾脏保护策略。